SE415354B - Forfarande for framstellning av xantinderivat - Google Patents
Forfarande for framstellning av xantinderivatInfo
- Publication number
- SE415354B SE415354B SE7310986A SE7310986A SE415354B SE 415354 B SE415354 B SE 415354B SE 7310986 A SE7310986 A SE 7310986A SE 7310986 A SE7310986 A SE 7310986A SE 415354 B SE415354 B SE 415354B
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- xanthine derivatives
- preparing xanthine
- preparing
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2335170A DE2335170C2 (de) | 1973-07-11 | 1973-07-11 | 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7310986L SE7310986L (sv) | 1975-01-13 |
| SE415354B true SE415354B (sv) | 1980-09-29 |
Family
ID=5886518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7310986A SE415354B (sv) | 1973-07-11 | 1973-08-10 | Forfarande for framstellning av xantinderivat |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4108995A (de) |
| AR (4) | AR199915A1 (de) |
| AT (1) | AT333300B (de) |
| BE (1) | BE816869R (de) |
| CA (1) | CA1062709A (de) |
| CH (4) | CH587851A5 (de) |
| DE (1) | DE2335170C2 (de) |
| DK (1) | DK147004C (de) |
| ES (3) | ES417828A1 (de) |
| FI (1) | FI61703C (de) |
| FR (1) | FR2236501B2 (de) |
| GB (1) | GB1480836A (de) |
| IE (1) | IE41822B1 (de) |
| NL (1) | NL168703C (de) |
| NO (2) | NO140596C (de) |
| SE (1) | SE415354B (de) |
| ZA (1) | ZA744373B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4207321A (en) * | 1977-04-02 | 1980-06-10 | Hoechst Aktiengesellschaft | Pharmaceutical compositions containing xanthines |
| DE3138397A1 (de) * | 1981-09-26 | 1983-04-07 | Hoechst Ag, 6230 Frankfurt | "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen" |
| US4636507A (en) * | 1984-04-30 | 1987-01-13 | Hoechst-Roussel Pharmaceuticals Inc. | Host defense mechanism enhancement |
| DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
| US5338741A (en) * | 1986-10-27 | 1994-08-16 | Nestec S.A. | 1-hydroxyalkylxanthines and medicaments containing them |
| DE3725554A1 (de) * | 1987-08-01 | 1989-02-09 | Hoechst Ag | Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung |
| DE3942871A1 (de) * | 1989-12-23 | 1991-06-27 | Hoechst Ag | R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel |
| EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
| US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
| WO1999031101A1 (en) * | 1997-12-17 | 1999-06-24 | University Of South Florida | Adenosine receptor antagonists with improved bioactivity |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2756229A (en) * | 1956-07-24 | Xanthine derivatives | ||
| US2517410A (en) * | 1947-08-15 | 1950-08-01 | Searle & Co | Hydroxy alkyl xanthines and the production thereof |
| DE926788C (de) * | 1952-11-07 | 1955-04-25 | Geigy Ag J R | Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen |
| FR1211333A (fr) * | 1955-10-19 | 1960-03-15 | Boehringer Sohn Ingelheim | Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines |
| DE1810705C3 (de) * | 1968-11-25 | 1980-11-27 | Hoechst Ag, 6000 Frankfurt | Stabilisierung von Vitaminen |
| DE1911279A1 (de) * | 1969-03-05 | 1970-11-12 | Eckert Dr Theodor | Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen |
-
1973
- 1973-07-11 DE DE2335170A patent/DE2335170C2/de not_active Expired
- 1973-08-02 CH CH1602476A patent/CH587851A5/xx not_active IP Right Cessation
- 1973-08-02 CH CH1602576A patent/CH587853A5/xx not_active IP Right Cessation
- 1973-08-02 CH CH1602376A patent/CH587852A5/xx not_active IP Right Cessation
- 1973-08-02 CH CH1124073A patent/CH587850A5/xx not_active IP Right Cessation
- 1973-08-03 AT AT684573A patent/AT333300B/de not_active IP Right Cessation
- 1973-08-09 DK DK438373A patent/DK147004C/da not_active IP Right Cessation
- 1973-08-10 SE SE7310986A patent/SE415354B/xx unknown
- 1973-08-10 CA CA178,591A patent/CA1062709A/en not_active Expired
- 1973-08-10 AR AR249530A patent/AR199915A1/es active
- 1973-08-10 NL NLAANVRAGE7311123,A patent/NL168703C/xx not_active IP Right Cessation
- 1973-08-11 ES ES417828A patent/ES417828A1/es not_active Expired
-
1974
- 1974-06-26 BE BE145889A patent/BE816869R/xx not_active IP Right Cessation
- 1974-06-28 GB GB28866/74A patent/GB1480836A/en not_active Expired
- 1974-07-05 FI FI2065/74A patent/FI61703C/fi active
- 1974-07-05 NO NO742464A patent/NO140596C/no unknown
- 1974-07-05 US US05/485,869 patent/US4108995A/en not_active Expired - Lifetime
- 1974-07-08 ZA ZA00744373A patent/ZA744373B/xx unknown
- 1974-07-08 FR FR7423606A patent/FR2236501B2/fr not_active Expired
- 1974-07-09 IE IE1456/74A patent/IE41822B1/en unknown
- 1974-10-01 AR AR255874A patent/AR200626A1/es active
- 1974-10-01 AR AR255872A patent/AR202662A1/es active
- 1974-10-01 AR AR255873A patent/AR202663A1/es active
-
1975
- 1975-04-29 ES ES437151A patent/ES437151A1/es not_active Expired
- 1975-04-29 ES ES437150A patent/ES437150A1/es not_active Expired
-
1979
- 1979-02-23 NO NO790627A patent/NO143064C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE416299B (sv) | Forfarande for framstellning av heterocykliska foreningar | |
| SE419981B (sv) | Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat | |
| SE453667B (sv) | Forfarande for framstellning av polyeterimider | |
| SE420201B (sv) | Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat | |
| SE397530B (sv) | Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat | |
| SE422798B (sv) | Analogiforfarande for framstellning av vincaminderivat | |
| SE420604B (sv) | Forfarande for framstellning av oxazolderivat | |
| SE411752B (sv) | Forfarande for framstellning av substituerade aminobensoesyraderivat | |
| SE428297B (sv) | Forfarande for framstellning av cefalosporansyraderivat | |
| SE420098B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE415354B (sv) | Forfarande for framstellning av xantinderivat | |
| SE7508074L (sv) | Forfarande for framstellning av stilbenderivat. | |
| SE419543B (sv) | Forfarande for framstellning av vissa angivna isokinolinderivat | |
| SE421129B (sv) | Forfarande for framstellning av poly-n-alkyl-iminoalaner | |
| SE387344B (sv) | Forfarande for framstellning av pyrazin-4-oxidderivat | |
| SE7613500L (sv) | Forfarande for framstellning av cefemderivat | |
| SE393376B (sv) | Forfarande for framstellning av pyrimidinonderivat | |
| SE415100B (sv) | Forfarande for framstellning av kinuklidin-kinolinderivat | |
| SE417966B (sv) | Forfarande for framstellning av pyrimidinoaminometyl-ergolinderivat | |
| SE421128B (sv) | Forfarande for framstellning av cefalosporansyraderivat | |
| SE419441B (sv) | Forfarande for framstellning av butyrofenonderivat | |
| SE409325B (sv) | Forfarande for framstellning av kinazolinonderivat | |
| SE7605364L (sv) | Forfarande for framstellning av antracenderivat | |
| SE419540B (sv) | Analogiforfarande for framstellning av vissa angivna n-hydroxiamidin-derivat | |
| SE429342B (sv) | Analogiforfarande for framstellning av cefalosporinderivat |